Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Global Drug Screening Market 2022-2032" report has been added to ResearchAndMarkets.com's offering.
This recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032.
The study offers a comprehensive assessment of the more important market dynamics.
After conducting thorough research on the historical and current growth parameters of the Drug Screening Market, the growth prospects of the market are obtained with maximum precision.
Key Topics Covered:
1. Executive Summary
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Drug Screening
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Drug Screening Market, by Key Countries
4.2. Drug Screening Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in Optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Drug Screening Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Drug Screening Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Drug Screening Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Drug Screening Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Product and Service
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product and Service, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product and Service, 2022-2032
8.3.1. Drug Screening Product
8.3.2. Analytical Instruments
8.3.2.1. Breathalyzers
8.3.2.1.1. Fuel Cell Breathalyzer
8.3.2.1.2. Semiconductor Breathalyzer
8.3.2.1.3. Other Breathalyzers
8.3.2.2. Immunoassay Analyzer
8.3.2.3. Chromatography Instruments
8.3.3. Rapid Testing Devices
8.3.3.1. Urine Testing Devices
8.3.3.1.1. Drug Testing Cups
8.3.3.1.2. Dip Cards
8.3.3.1.3. Drug Testing Cassetts
8.3.3.2. Oral Fluid Testing Devices
8.3.4. Consumables
8.3.4.1. Assay Kits
8.3.4.2. Sample Collection Devices
8.3.4.3. Calibrators & Controls
8.3.4.4. Other Consumables
8.3.5. Drug Screening Service
8.4. Market Attractiveness Analysis By Product and Service
9. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By End User
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
9.3.1. Drug Testing Laboratories
9.3.2. Workplaces
9.3.3. Criminal Justice and Law Enforcement Agencies
9.3.4. Hospitals
9.3.5. Drug Treatment Centers
9.3.6. Individual Users
9.3.7. Pain Management Centers
9.3.8. Schools and Colleges
9.4. Market Attractiveness Analysis By End User
10. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Sample Type
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Sample Type, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2022-2032
10.3.1. Urine Samples
10.3.2. Breath Samples
10.3.3. Oral Fluid Samples
10.3.4. Hair Samples
10.3.5. Other Samples
10.4. Market Attractiveness Analysis By Sample Type
11. Global Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
13. Latin America Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
14. Europe Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
15. Asia Pacific Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
16. Middle East and Africa Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
17. Key Countries Drug Screening Market Analysis 2015-2021 and Forecast 2022-2032
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. LABCORP
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. QUEST DIAGNOSTICS
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. ABBOTT LABORATORIES
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. ORASURE TECHNOLOGIES
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. ALFA SCIENTIFIC DESIGNS
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. THERMO FISHER SCIENTIFIC
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. DRAGERWERK
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. LIFELOC TECHNOLOGIES
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. MPD INC.
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. OMEGA LABORATORIES
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/t2k8m6
